Loading…
Legislative Progress
Introduced
October 15, 2021
Latest Action
October 18, 2021
Primary Sponsor
Bonnie Watson ColemanDemocratic(NJ)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
59pct
3d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
PrEP Assistance Program Act This bill establishes a grant program to provide pre-exposure prophylaxis (PrEP) and related services to individuals at no cost. PrEP is medication given to individuals at risk of HIV to reduce their likelihood of contracting the virus. The Department of Health and Human Services must award the grants to state, tribal, and local governments; certain health clinics; and community-based organizations.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2022 · third_quarter · Health Issues
H.R. 623: Gabriella Miller Kids First Research Act 2.0 H.R. 724: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2021 - Provisions related to FDA drug approval process H.R. 832: Safe and Affordable Drugs from Canada Act of 2021 - Provisions related to prescription drug importation H.R. 1400: COVID-19 Health Disparities Action Act of 2021 - Provisions related to COVID-19 vaccines H.R. 1730: Speeding Therapy Access Today Act of 2021 - Provisions related to FDA policy and health research H.R. 1873: Advancing Education on Biosimilars Act of 2021 - Provisions related to biologics and biosimilar products H.R.1978 - Protecting Seniors Through Immunization Act of 2021 H.R. 2181: Affordable and Safe Prescription Drug Importation Act - Provisions related to prescription drug importation H.R. 2565: FDA Modernization Act of 2021 - Provisions related to FDA policy and health research H.R. 2815: BIOSIM Act - Provisions related to biosimilars and prescription drug pricing H.R. 2831: Prompt Approval of Safe Generic Drugs Act- Provisions related to FDA policy and approvals H.R. 2843: STOP GAMES Act of 2021 - Provisions related to citizen petitions H.R. 2869: Increasing Access to Biosimilars Act of 2021 - Provisions related to biosimilars and prescription drug pricing H.R. 3761: Promising Pathways Act - Provisions related to FDA policy H.R. 3932: PASTEUR Act of 2021 - Provisions related to antimicrobial resistance policy issues S. 4348: FDASLA Act of 2022 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes H.R. 4390: PROTECT 340B Act of 2021 - Provisions related to 340B drug discount program H.R. 4472: BENEFIT Act of 2021 - Provisions related to FDA policy H.R. 4511: FDA Advancing Collection of Transformative Science Act or the FACTS Act H.R. 5030: DIVERSE Trials Act- Diversifying Investigations Via Equitable Research Studies for Everyone H.R. 5376: Inflation Reduction Act of 2022 (P.L. 117-169) H.R. 5416: Give Kids a Chance Act H.R. 5585: Advanced Research Project Agency-Health Act - Provisions related to health research S. 581/H.R. 2170: HAPI Act; Medicaid financial barriers HR 5605 PrEP Assistance Act H.R. 5801: HELP Copays Act - Provisions related to prescription drug pricing and cost-sharing H.R. 6000: Cures 2.0 Act - Provisions related to health research H.R. 6584: DEPICT Act - To direct the Commissioner of Food and Drugs to amend certain regulations to increase clinical trial diversity, and for other purposes H.R. 6963: Accelerated Approval Integrity Act of 2022 - Provisions related to accelerated approval H.R. 6972: Give Kids a Chance Act of 2022 - Provisions related to additional authorities and pediatric investigations H.R. 6973: Enhanced Access to Affordable Medicines Act of 2022 - Provisions related to labeling H.R. 6988: Drug Manufacturing Innovation Act of 2022 H.R. 6996: Accelerating Access for Patients Act of 2022 H.R. 7006: Improving the Nations Safe Pharmaceuticals and Excipients by Creating Tools for Inspecting and Overseeing Needed Supplies Act or the INSPECTIONS Act H.R. 7008: Pre-Approval Information Exchange Act of 2022 H.R. 7032: Increasing Transparency in Generic Drug Applications Act of 2022 H.R. 7047: Lowering Costs by Improving Biosimilar Uptake Act H.R. 7474: Pharmaceutical Research and Transparency Act of 2022 H.R. 7667: Food and Drug Amendments Act of 2022 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes H.R. 7845: NIH Clinical Trial Diversity Act of 2022 H.R. 8152: American Data Privacy and Protection Act H.R. 5376 Inflation Reduction Act - provisions related to vaccines and pharmaceuticals H.R. 4127: DISARM Act Act Provisions related to antimicrobial drug development H.R. 3932/S. 2076: PASTEUR Act - authorizes the Department of Health and Human Services (HHS) to enter into subscription contracts for critical-need antimicrobial drugs. H.R. 3655: Vaccine Injury Compensation Modernization Act H.R. 550: Immunization Infrastructure Modernization Act (IIS harmonization) S. 912/H.R. 1978: Protecting Seniors Through Immunization Act H.R. 3656/S. 3087: Vaccine Access Improvement Act (VICP program changes) S. 154: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2021- Provisions related to FDA drug approval process S. 164: Advancing Education on Biosimilars Act of 2021 - Provisions related to biologics and biosimilar products S. 259: Safe and Affordable Drugs from Canada Act of 2021 - Provisions related to prescription drug importation S. 562: Ensuring Timely Access to Generics Act of 2021 - Provisions related to citizen petitions S. 773: A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes - Provisions related to 340B drug discount program S. 920: Affordable and Safe Prescription Drug Importation Act - Provisions related to prescription drug importation S. 1425: Stop STALLING Act - Provisions related to citizen petitions S. 1427: Increasing Access to Biosimilars Act of 2021 - Provisions related to biosimilars and prescription drug pricing S. 1462: Simplifying the Generic Drug Application Process Act - Provisions related to FDA policy and approvals S. 1644: Promising Pathway Act - Provisions related to FDA policy S. 1645: ADAPT Act - Provisions related to FDA policy S. 2076: PASTEUR Act of 2021 - Provisions related to antimicrobial resistance policy issues S. 2706: DIVERSE Trials Act - Provisions related to FDA policy S. 2837: 340B Accountability Act of 2021 - Provisions related to 340B drug discount program S. 2983: ADAPT for COVID Act - Provisions related to FDA accelerated approval pathways S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act or PREVENT Pandemics Act S. 4215: Give Kids a Chance Act of 2022 S. 4348: FDASLA Act of 2022 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes S. 4430: Interagency Patent Coordination and Improvement Act of 2022 S. 4535: Food and Drug Administration Simple Reauthorization Act of 2022 S. 4918: Increasing Prescription Drug Competition Act - Patent-related policy issues Cancer Moonshot Initiative Healthy Future Task Force RFIs - Severity, Affordability, Modernization and Treatments 21st Century Cures 2.0 Department of Homeland Security cybersecurity policy issues Dietary Supplement Health and Education Act Reform Drug cost and pricing policy issues Principles for drug pricing reform Drug importation policy issues Drug counterfeiting policy issues Direct to consumer advertising policy issues PDUFA reauthorization BsUFA reauthorization Competition policy issues Expanded access policy issues Antimicrobial resistance (AMR) policy issues Supply chain and foreign manufacturing policy issues Real world evidence policy issues Clinical trial diversity policy issues Prescription drug abuse and fentanyl policy issues 340B drug discount program policy issues Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues COVID-19 policy issues Pandemic preparedness policy issues Defense Production Act (DPA) policy issues High deductible health plans/HSA and FSA for dietary supplements policy issues Final Rule; Importation of Prescription Drugs Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act CREATES/USICA INFORM Consumers Act SHOP SAFE Act Food and Drug Amendments of 2022 Buy America and other associated issues related to procurement and sourcing of finished product and active pharmaceutical ingredients Veterans' Affairs issues related to product sampling Senate Amendment to H.R. 3684, Infrastructure Investment and Jobs Act, provisions related to Medicare Part B and drug rebates H.R. 4121, PRO Seniors Act, provisions related to drug rebates Protecting American Innovation Act, provisions related to intellectual property
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $1,390,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2022 · third_quarter · Health Issues
Conversion Therapy Ending Discrimination Against Gay and Bisexual Blood and Tissue Donors Financial Services and General Government Appropriations Funding for HIV/AIDS Education, Prevention, and Research Funding for and Education Regarding Comprehensive Sexual Health Education Implementation of Section 1557 Nondiscrimination regulations Implementation and Protection of the Patient Protection and Affordable Care Act Interpretation of the Older Americans Act Labor, HHS, and Education Appropriations LGBTQ Data Collection Labor, HHS, and Education Appropriations PrEP Insurance Coverage Title X Family Planning Funding Preventing Prohibitions on Gender Transition-Related Care Privacy in Health Insurance Explanation of Benefits Religious Refusals in Healthcare Repeal of Federal Ban on Funding for Syringe Exchange Programs Ryan White CARE Program Reauthorization Unfair Drug Pricing Practices FDA Ban on Blood Donation by MSM COVID-19 Legislative Response Older Americans Act Real Education for Healthy Youth Act (H.R. 3312, S. 1689) Therapeutic Fraud Prevention Act (H.R. 4146; S. 2242) Eliminating the HHS Discrimination Division Act of 2021 (H.R. 4265) Womens Health Protection Act (H.R. 3755, S.1975) Womens Health Protection Act (H.R. 8296) PrEP Assistance Program Act (H.R. 5605) Abortion is Health Care Everywhere Act of 2021 (H.R. 1670) PrEP Access and Coverage Act (H.R. 6117, S. 3295) 9-8-8 Implementation Act of 2021 (H.R. 7116) Abortion is Health Care Everywhere Act of 2022 (S. 4641)
Client expense: $224,764 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Natl AIDS Policy, SENATE, White House Office
2022 · second_quarter · Health Issues
Conversion Therapy Ending Discrimination Against Gay and Bisexual Blood and Tissue Donors Financial Services and General Government Appropriations Funding for HIV/AIDS Education, Prevention, and Research Funding for and Education Regarding Comprehensive Sexual Health Education Implementation of Section 1557 Nondiscrimination regulations Implementation and Protection of the Patient Protection and Affordable Care Act Interpretation of the Older Americans Act Labor, HHS, and Education Appropriations LGBTQ Data Collection Labor, HHS, and Education Appropriations PrEP Insurance Coverage Title X Family Planning Funding Preventing Prohibitions on Gender Transition-Related Care Privacy in Health Insurance Explanation of Benefits Religious Refusals in Healthcare Repeal of Federal Ban on Funding for Syringe Exchange Programs Ryan White CARE Program Reauthorization Unfair Drug Pricing Practices FDA Ban on Blood Donation by MSM COVID-19 Legislative Response Older Americans Act Prohibition of Medicaid Funding for Conversion Therapy Act (H.R. 2328) Supporting the goals and ideals of National Youth HIV & AIDS Awareness Day (H.Res. 296) Healthy Families Act (H.R. 2465; S. 1195) Real Education for Healthy Youth Act (H.R. 3312, S. 1689) Therapeutic Fraud Prevention Act (H.R. 4146; S. 2242) Eliminating the HHS Discrimination Division Act of 2021 (H.R. 4265) HIV Epidemic Loan-Repayment Program (HELP) Act (H.R. 2295) Health Equity and Accountability Act (H.R. 7585) Expressing the sense of the House of Representatives that blood donation policies in the United States should be equitable and based on science. (H.Res 290) HIV Epidemic Loan-Repayment Program (HELP) Act (H.R. 2295) Reproductive Rights are Human Rights Act (H.R. 3576; S.1864) Womens Health Protection Act (H.R. 3755, S.1975) Womens Health Protection Act (H.R. 8296) PrEP Assistance Program Act (H.R. 5605) Abortion is Health Care Everywhere Act of 2021 (H.R. 1670) PrEP Access and Coverage Act (H.R. 6117, S. 3295) 9-8-8 Implementation Act of 2021 (H.R. 7116) HELP Act of 2021 (H.R.2295) Pride in Mental Health Act (H.R. 7644) Ensuring Access to Abortion Act (H.R. 8297)
Client expense: $316,568 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Natl AIDS Policy, SENATE, White House Office
2022 · first_quarter · Health Issues
Conversion Therapy Ending Discrimination Against Gay and Bisexual Blood and Tissue Donors Financial Services and General Government Appropriations Funding for HIV/AIDS Education, Prevention, and Research Funding for and Education Regarding Comprehensive Sexual Health Education Implementation of Section 1557 Nondiscrimination regulations Implementation and Protection of the Patient Protection and Affordable Care Act Interpretation of the Older Americans Act Labor, HHS, and Education Appropriations LGBTQ Data Collection Labor, HHS, and Education Appropriations PrEP Insurance Coverage Title X Family Planning Funding Preventing Prohibitions on Gender Transition-Related Care Privacy in Health Insurance Explanation of Benefits Religious Refusals in Healthcare Repeal of Federal Ban on Funding for Syringe Exchange Programs Ryan White CARE Program Reauthorization Unfair Drug Pricing Practices FDA Ban on Blood Donation by MSM COVID-19 Legislative Response Older Americans Act Prohibition of Medicaid Funding for Conversion Therapy Act (H.R. 2328) Supporting the goals and ideals of National Youth HIV & AIDS Awareness Day (H.Res. 296) Youth Access to Sexual Health Services Act Healthy Families Act (H.R. 2465; S. 1195) Real Education and Access for Healthy Youth Act of 2021 ( S. 1689 and H.R. 3312) Therapeutic Fraud Prevention Act (H.R. 4146; S. 2242) Eliminating the HHS Discrimination Division Act (H.R. 4023) HIV Epidemic Loan-Repayment Program (HELP) Act (H.R. 2295) Community Solutions for COVID-19 Act Health Equity and Accountability Act Pursuing Equity in Mental Health Act (H.R. 1475 and S. 1795) COVID-19 Health Disparities Action Act (H.R. 1400 and S. 465) COVID-19 in Corrections Data Transparency Act (H.R. 1072 and S. 324) Improving Social Determinants of Health Act of 2021 (H.R. 379, S. 104) Science in Blood Donation Act Expressing the sense of the House of Representatives that blood donation policies in the United States should be equitable and based on science. (H.Res 290) World AIDS Day Resolution (S.Res. 461) COVID Community Care Act (H.R. 1835) HIV Epidemic Loan-Repayment Program (HELP) Act Reproductive Rights are Human Rights Act (H.R. 3576; S.1864) Womens Health Protection Act (H.R. 3755, S.1975) PrEP Assistance Program Act (H.R. 5605) Abortion is Health Care Everywhere Act of 2021 (H.R. 1670) PrEP Access and Coverage Act (H.R. 6117, S. 3295) 9-8-8 Implementation Act of 2021 (H.R.7116) HELP Act of 2021 (H.R.2295) Consolidated Appropriations Act, 2022 (H.R. 2471)
Client expense: $147,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Natl AIDS Policy, SENATE, White House Office
2021 · fourth_quarter · Health Issues
Conversion Therapy Ending Discrimination Against Gay and Bisexual Blood and Tissue Donors Financial Services and General Government Appropriations Funding for HIV/AIDS Education, Prevention, and Research Funding for and Education Regarding Comprehensive Sexual Health Education Implementation of Section 1557 Nondiscrimination regulations Implementation and Protection of the Patient Protection and Affordable Care Act Interpretation of the Older Americans Act Labor, HHS, and Education Appropriations LGBTQ Data Collection Labor, HHS, and Education Appropriations PrEP Insurance Coverage Title X Family Planning Funding Preventing Prohibitions on Gender Transition-Related Care Privacy in Health Insurance Explanation of Benefits Religious Refusals in Healthcare Repeal of Federal Ban on Funding for Syringe Exchange Programs Ryan White CARE Program Reauthorization Unfair Drug Pricing Practices FDA Ban on Blood Donation by MSM COVID-19 Legislative Response Older Americans Act Prohibition of Medicaid Funding for Conversion Therapy Act (H.R. 2328) Supporting the goals and ideals of National Youth HIV & AIDS Awareness Day Youth Access to Sexual Health Services Act PrEP Access and Coverage Act Healthy Families Act (H.R. 2465; S. 1195) Real Education for Healthy Youth Act Therapeutic Fraud Prevention Act (H.R. 4146; S. 2242) Eliminating the HHS Discrimination Division Act HIV Epidemic Loan-Repayment Program (HELP) Act (H.R. 2295) Community Solutions for COVID-19 Act Health Equity and Accountability Act Pursuing Equity in Mental Health Act COVID-19 Health Disparities Action Act COVID-19 in Corrections Data Transparency Act Improving Social Determinants of Health Act of 2021 (H.R. 379, S. 104) Science in Blood Donation Act Expressing the sense of the House of Representatives that blood donation policies in the United States should be equitable and based on science. World AIDS Day Resolution COVID Community Care Act (H.R. 1835) HIV Epidemic Loan-Repayment Program (HELP) Act Reproductive Rights are Human Rights Act (H.R. 3576; S.1864) Womens Health Protection Act (H.R. 3755, S.1975) PrEP Assistance Program Act (H.R. 5605) Abortion is Health Care Everywhere Act of 2021 (H.R. 1670) PrEP Access and Coverage Act (H.R. 6117, S. 3295)
Client expense: $175,000 · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Administration on Aging, Centers For Disease Control & Prevention (CDC), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl AIDS Policy, Office of Personnel Management (OPM), Office on Violence Against Women, SENATE, Social Security Administration (SSA), State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
2021 · third_quarter · Health Issues
Conversion Therapy Ending Discrimination Against Gay and Bisexual Blood and Tissue Donors Financial Services and General Government Appropriations Funding for HIV/AIDS Education, Prevention, and Research Funding for and Education Regarding Comprehensive Sexual Health Education Implementation of Section 1557 Nondiscrimination regulations Implementation and Protection of the Patient Protection and Affordable Care Act Interpretation of the Older Americans Act Labor, HHS, and Education Appropriations LGBTQ Data Collection Labor, HHS, and Education Appropriations PrEP Insurance Coverage Title X Family Planning Funding Preventing Prohibitions on Gender Transition-Related Care Privacy in Health Insurance Explanation of Benefits Religious Refusals in Healthcare Repeal of Federal Ban on Funding for Syringe Exchange Programs Ryan White CARE Program Reauthorization Unfair Drug Pricing Practices FDA Ban on Blood Donation by MSM COVID-19 Legislative Response Older Americans Act Prohibition of Medicaid Funding for Conversion Therapy Act (H.R. 2328) Supporting the goals and ideals of National Youth HIV & AIDS Awareness Day Youth Access to Sexual Health Services Act PrEP Access and Coverage Act Real Education for Healthy Youth Act Therapeutic Fraud Prevention Act Eliminating the HHS Discrimination Division Act HIV Epidemic Loan-Repayment Program (HELP) Act (H.R. 2295) Community Solutions for COVID-19 Act Health Equity and Accountability Act Pursuing Equity in Mental Health Act COVID-19 Health Disparities Action Act COVID-19 in Corrections Data Transparency Act Improving Social Determinants of Health Act of 2021 (H.R. 379, S. 104) Science in Blood Donation Act Expressing the sense of the House of Representatives that blood donation policies in the United States should be equitable and based on science. World AIDS Day Resolution COVID Community Care Act HIV Epidemic Loan-Repayment Program (HELP) Act Reproductive Rights are Human Rights Act (H.R. 3576; S.1864) Womens Health Protection Act (H.R. 3755) PrEP Assistance Program Act (H.R. 5605) Women's Health Protection Act (S. 1975) Abortion is Health Care Everywhere Act of 2021 (H.R. 1670)
| Democratic |
| NC |
| André Carson | Democratic | IN |
| Ann M. Kuster | Democratic | NH |
| Anthony G. Brown | Democratic | MD |
| Ayanna Pressley | Democratic | MA |
| Barbara Lee | Democratic | CA |
| Bennie G. Thompson | Democratic | MS |
| Brian Higgins | Democratic | NY |
| Carolyn B. Maloney | Democratic | NY |
| Chris Pappas | Democratic | NH |
| Colin Z. Allred | Democratic | TX |
| Cori Bush | Democratic | MO |
| David N. Cicilline | Democratic | RI |
| Derek Kilmer | Democratic | WA |
| Dina Titus | Democratic | NV |
| Donald M. Payne, Jr. | Democratic | NJ |
| Dwight Evans | Democratic | PA |
| Earl Blumenauer | Democratic | OR |
| Eddie Bernice Johnson | Democratic | TX |
| Eleanor Holmes Norton | Democratic | DC |
| Grace Meng | Democratic | NY |
| Greg Stanton | Democratic | AZ |
| Gregory W. Meeks | Democratic | NY |
| Gwen Moore | Democratic | WI |
| Henry C. "Hank" Johnson, Jr. | Democratic | GA |
| Ilhan Omar | Democratic | MN |
| Jamaal Bowman | Democratic | NY |
| Jamie Raskin | Democratic | MD |
| Janice D. Schakowsky | Democratic | IL |
| Jerrold Nadler | Democratic | NY |
| Jim Cooper | Democratic | TN |
| Jimmy Gomez | Democratic | CA |
| John B. Larson | Democratic | CT |
| Judy Chu | Democratic | CA |
| Karen Bass | Democratic | CA |
| Katie Porter | Democratic | CA |
| Lisa Blunt Rochester | Democratic | DE |
| Lois Frankel | Democratic | FL |
| Lucille Roybal-Allard | Democratic | CA |
| Marc A. Veasey | Democratic | TX |
| Marilyn Strickland | Democratic | WA |
| Mark DeSaulnier | Democratic | CA |
| Mark Pocan | Democratic | WI |
| Mark Takano | Democratic | CA |
| Mary Gay Scanlon | Democratic | PA |
| Maxine Waters | Democratic | CA |
| Melanie A. Stansbury | Democratic | NM |
| Mike Quigley | Democratic | IL |
| Mikie Sherrill | Democratic | NJ |
| Mondaire Jones | Democratic | NY |
| Nanette Diaz Barragán | Democratic | CA |
| Nikema Williams | Democratic | GA |
| Nydia M. Velázquez | Democratic | NY |
| Paul Tonko | Democratic | NY |
| Peter A. DeFazio | Democratic | OR |
| Peter Welch | Democratic | VT |
| Rashida Tlaib | Democratic | MI |
| Sean Casten | Democratic | IL |
| Sheila Cherfilus-McCormick | Democratic | FL |
| Stephen F. Lynch | Democratic | MA |
| Steve Cohen | Democratic | TN |
| Steven Horsford | Democratic | NV |
| Sylvia R. Garcia | Democratic | TX |
| Teresa Leger Fernandez | Democratic | NM |
| Terri A. Sewell | Democratic | AL |
| Tom O’Halleran | Democratic | AZ |
| William R. Keating | Democratic | MA |
Client expense: $170,000 · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Administration on Aging, Centers For Disease Control & Prevention (CDC), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl AIDS Policy, Office of Personnel Management (OPM), Office on Violence Against Women, SENATE, Social Security Administration (SSA), State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office